Date: October 24, 2019 Start Time: 09.30
Location: INAB’s Seminar Room
Speaker: Elsa Vlachonikola, Ph.D candidate, AUTH-INAB
Title: Longitudinal T Cell Immunoprofiling of Patients with Relapsed and/or Refractory Myeloma Who Receive Daratumumab Monotherapy: A Subanalysis of a Phase 2 Study (the REBUILD Study).
